Ultrasound Versus Fluoroscopy-guided Selective Lumbar Nerve Root Injection

September 26, 2022 updated by: Islam Ahmed Bakr Mohammed, Minia University

Ultrasound Versus Fluoroscopy-guided Selective Lumbar Nerve Root Injection for Treatment of Radicular Pain

The study is conducted to compare pain relief, accuracy and safety and radiation exposure of selective lumbar nerve root injection for lumbar radicular pain using ultrasound guidance versus fluoroscopy guidance

Study Overview

Status

Completed

Detailed Description

Radicular pain is believed to be induced by irritation or inflammation of a nerve root caused by mechanical pressure or chemical irritation from degeneration herniation or rupture of intervertebral disc .Nerve root steroid injection is the most commonly performed minimally invasive technique for treatment of radicular pain in lumbar spine.The mechanism of action of steroids is to reduce inflammation by reduction in proinflammatory mediators around the nerve root, causing reduction in pain levels . Although Fluoroscopy guided technique is the most widely accepted method in lumbar selective nerve root injection, but recently ultrasound technique has gained acceptance among physicians due its reliability, efficacy, real-time guidance of injection and reduction of radiation exposure. Real-time guidance of injection provided by ultrasonography allows for good identification of the spinous process and adjacent structures such as lamina, zygapophyseal articulations and transverse process allowing for safer and potentially equally effective injection technique. The patients are randomly allocated into two groups; one group will receive injection under fluoroscopy guidance and the other group will receive injection under ultrasound guidance. The two groups are compared in terms of pain relief, accuracy and safety and radiation exposure.

Study Type

Interventional

Enrollment (Actual)

74

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Minya, Egypt, 61111
        • Faculty of medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • adult patients aged 18-60 years .
  • Both sexes .
  • With unilateral chronic lumbar radicular pain for more than 3 months.
  • Cooperative and oriented patients.
  • All patients are diagnosed by a neurologist for radicular low back pain through clinical presentation, medical examinations, computed tomography (CT), or magnetic resonance imaging (MRI).

Exclusion Criteria:

  • Uncontrolled diabetes.
  • Infection at the site of injection.
  • Spine fractures.
  • Previous back surgery.
  • Progressive neurologic disorders.
  • Fever.
  • Peripheral neuropathy.
  • Presence of motor or sphencteric disturbance.
  • Bilateral radicular pain.
  • Allergy to substance of injection.
  • Patients with body mass index (BMI) more than 35.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: ultrasound
selective lumbar nerve root steroid injection under ultrasound guidance.
selective lumbar nerve root steroid injection for treatment of radicular pain.
Sham Comparator: fluoroscopy
selective lumbar nerve root steroid injection under fluoroscopy guidance.
selective lumbar nerve root steroid injection for treatment of radicular pain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
improvement of visual analogue score of pain
Time Frame: 3 months
evaluation of pain relief using visual analogue score on a scale from 0 to 10 with higher scores mean worse outcome
3 months
improvement of Oswestry disability index score for back pain
Time Frame: 3 months
evaluation of pain relief using Oswestry disability index score on a scale from 0% to 100% with the higher scores mean worse outcome.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
safety of technique
Time Frame: 3 months
comparing rate of complications
3 months
radiation exposure
Time Frame: 1 hour
time of x-ray radiation exposure during procedure.
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Amany K Abu Elhusein, PhD, Professor of Anesthesia and intensive care, MiniaU.
  • Study Director: Abd ELraheem M Mohamed, MD, Assistant professor of Anesthesia and intensive care, AsuitU..

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 6, 2021

Primary Completion (Actual)

April 12, 2022

Study Completion (Actual)

May 16, 2022

Study Registration Dates

First Submitted

February 25, 2022

First Submitted That Met QC Criteria

March 11, 2022

First Posted (Actual)

March 22, 2022

Study Record Updates

Last Update Posted (Actual)

September 27, 2022

Last Update Submitted That Met QC Criteria

September 26, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lumbar Radiculopathy

Clinical Trials on selective lumbar nerve root injection

3
Subscribe